FGF23 in Acute and Chronic Illness
Joint Authors
Schnedl, Christian
Fahrleitner-Pammer, Astrid
Pietschmann, Peter
Amrein, Karin
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-09-28
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
FGF23 is a bone-derived phosphaturic hormone that may become a useful biomarker for the identification of high-risk patients in chronic but also acute disease.
It rises early in chronic kidney disease and is strongly and independently associated with excess morbidity and mortality.
Emerging data suggest that FGF23 is also elevated in different scenarios of acute illness.
In this review, we give an overview on the role of this interesting disease marker and potential and proven interventional strategies and discuss a blueprint for future research.
American Psychological Association (APA)
Schnedl, Christian& Fahrleitner-Pammer, Astrid& Pietschmann, Peter& Amrein, Karin. 2015. FGF23 in Acute and Chronic Illness. Disease Markers،Vol. 2015, no. 2015, pp.1-8.
https://search.emarefa.net/detail/BIM-1060919
Modern Language Association (MLA)
Schnedl, Christian…[et al.]. FGF23 in Acute and Chronic Illness. Disease Markers No. 2015 (2015), pp.1-8.
https://search.emarefa.net/detail/BIM-1060919
American Medical Association (AMA)
Schnedl, Christian& Fahrleitner-Pammer, Astrid& Pietschmann, Peter& Amrein, Karin. FGF23 in Acute and Chronic Illness. Disease Markers. 2015. Vol. 2015, no. 2015, pp.1-8.
https://search.emarefa.net/detail/BIM-1060919
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1060919
